AM240 MCR News
Most Popular AM240 MCR Story
AnaMar raises $9.6M for RA work
Sweden's AnaMar Medical has raised SEK 75 million ($9.6 million) to fund a phase I study of AM240 MCR for rheumatoid arthritis. The funds are provided through a rights issue guaranteed by AnaMar's Read more...
Latest Headlines
- November 6, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
